Cargando…
Intrathecal Drug Delivery Systems for Cancer Pain: An Analysis of a Prospective, Multicenter Product Surveillance Registry
BACKGROUND: The safety and efficacy of intrathecal drug delivery systems (IDDSs) for the treatment of cancer-related pain have been demonstrated in randomized controlled clinical trials (RCTs). Despite positive evidence for this therapy, IDDS remains underutilized to treat cancer pain. Real-world re...
Autores principales: | Stearns, Lisa M., Abd-Elsayed, Alaa, Perruchoud, Christophe, Spencer, Robert, Hammond, Krisstin, Stromberg, Katherine, Weaver, Todd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948791/ https://www.ncbi.nlm.nih.gov/pubmed/31567325 http://dx.doi.org/10.1213/ANE.0000000000004425 |
Ejemplares similares
-
Targeted Drug Delivery for Chronic Nonmalignant Pain: Longitudinal Data From the Product Surveillance Registry
por: Schultz, David M., et al.
Publicado: (2021) -
Intrathecal Baclofen for Severe Spasticity: Longitudinal Data From the Product Surveillance Registry
por: Schiess, Mya Caryn, et al.
Publicado: (2020) -
Health Services Utilization and Payments in Patients With Cancer Pain: A Comparison of Intrathecal Drug Delivery vs. Conventional Medical Management
por: Stearns, Lisa J., et al.
Publicado: (2016) -
Intrathecal Drug Delivery Systems (IDDS): The Implantable Systems Performance Registry (ISPR)
por: Konrad, Peter E., et al.
Publicado: (2016) -
Intrathecal Drug Delivery: Advances and Applications in the Management of Chronic Pain Patient
por: De Andres, Jose, et al.
Publicado: (2022)